Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
PaperCitations, authors & open-access status
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 469 citations, 2022 year and green oa status.
469
Citations
2022
Year
green
OA Status